Source: International Congress 2016 – Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Heleen A. Crommelin (Nieuwegein, Netherlands), Heleen A. Crommelin, Leone M. van der Burg, Adriane D.M. Vorselaars, Marjolein Drent, Coline H.M. van Moorsel, Ger T. Rijkers, Vera H.M. Deneer, Jan C. Grutters. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Eur Respir J 2016; 48: Suppl. 60, 820

Member's Comments

No comment yet.

Related content which might interest you: Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases Year: 2015 Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis Source: Eur Respir J 2014; 44: 1296-1307 Year: 2014 Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Relapse after discontinuation of infliximab in sarcoidosis patients can be predicted by PET-scan and sIL-2R Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial Source: Eur Respir J 2008; 31: 1189-1196 Year: 2008 Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Sarcoidosis relapses in corticosteroid treated patients Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Adalimumab and etanercept induced asthma Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis Source: Eur Respir J 2014; 43: 602-609 Year: 2013 Corticosteroid treatment in sarcoidosis Source: Eur Respir J 2006; 28: 627-636 Year: 2006 Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Therapeutic options for sarcoidosis: old and new Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005 Infliximab for treating sarcoidosis, portuguese experience Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Late Breaking Abstract - Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013